Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma

Serum hepatitis B core-related antigen (HBcrAg) was shown to predict the risk of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients undergoing treatment. We investigated the longitudinal profile of HBcrAg in entecavir (ETV)-treated CHB patients with subsequent HCC development. We i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mak, Lung-Yi, Ko, Kwan-Lung, To, Wai-Pan, Wong, Danny Ka-Ho, Seto, Wai-Kay, Fung, James, Yuen, Man-Fung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492492/
https://www.ncbi.nlm.nih.gov/pubmed/32457279
http://dx.doi.org/10.5009/gnl19434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492492/
https://www.ncbi.nlm.nih.gov/pubmed/32457279
http://dx.doi.org/10.5009/gnl19434

Ejemplares similares